Delivery Order SPE2DB20D3104-SPE2DB25FV8C4

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $1,103.74, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 19, 2024. It is not associated with a set-aside designation. Amerisourcebergen holds...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,052.14 to supply Testosterone Cypionate 200 mg/ml. The contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range...
This is a $1,416.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Testosterone CYP 200 mg/mL. The contract is not set aside and has an ultimate completion date of June 11, 2025. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies in support...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL medication, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,652.80 firm fixed-price contract has a completion date of July 18, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider supplying medical products to federal government agencies, including military and veterans' healthcare systems. This award is...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product called Testosterone CYP 200 mg/mL. The award, valued at $2,090.59, has a completion date of February 13, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and this order is issued under an Indefinite Delivery Contract (IDC) with DLA valued at up...
This federal contract award is for the delivery of testosterone CYP 200 mg/ml medication to the Defense Logistics Agency (DLA), a major defense agency within the U.S. Department of Defense. The prime contractor for this $3,940.00 firm fixed-price delivery order is Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,248.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of testosterone 1% (50 mg/5 g) pharmaceutical product, with an ultimate completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to provide a comprehensive...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of testosterone cypionate 200 mg/ml. The $1,358.10 firm fixed-price contract has a completion date of March 31, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of...
This federal contract award, valued at $1,074.35, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of testosterone 1% (25mg/2.5g) pharmaceutical products to support military treatment programs and facilities. The contract is a firm fixed price delivery order, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp serves as the prime...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,564.09, is for the delivery of a pharmaceutical product - Testosterone 1% (50 mg/5 g) in a 5 g pack. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV8C4
    Delivery Order

This federal contract award is for the delivery of Testosterone CYP 200 mg/ml, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,494.48 and a period of performance through June 11, 2025. The contract is not set aside and was competed openly.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/9/25, 12:56 PM